About Arkios BioDevelopment International
Arkios BioDevelopment International is a full service contract research organization (CRO) providing services to emerging to medium-sized technology companies developing new drugs, biologics, medical devices, and diagnostics.
Arkios focuses on assisting biopharmaceutical and device companies with the early stages of regulatory strategic planning and implementation, the writing and filing of successful Investigational New Drug/Investigational Device Exemptions (IND/IDE), FDA conferencing through approval. Arkios also provides comprehensive clinical development services in the biopharmaceutical and device areas. We have recently added the preparation and filing of electronic CTDs (eCTDs) to our capabilities. Arkios can provide specific services or a comprehensive management program for our clients.
We specialize in working with small US companies, and foreign companies seeking approval of their products in the USA.